3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Status
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
3
Thoracic
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Conditions
Frailty
5
Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Lung Neoplasms
2
Urogenital Neoplasms
1
Solid Neoplasm
1
Sarcopenia
1
Sarcoma
1
Ovarian Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Hepatic Malignancies
1
Hematopoietic and Lymphoid System Neoplasm
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Health Education
1
Head and Neck Neoplasms
1
Communication
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Fulvestrant
125
Trastuzumab
114
Paclitaxel
113
Letrozole
108
pembrolizumab
79
pertuzumab
75
palbociclib
75
Capecitabine
72
Anastrozole
72
Cyclophosphamide
70
Carboplatin
67
abemaciclib
64
exemestane
63
Tamoxifen
63
ribociclib
60
trastuzumab deruxtecan
57
Surveys and Questionnaires
51
Specimen Handling
50
Radiotherapy
49
Docetaxel
49
Magnetic Resonance Spectroscopy
48
Blood Specimen Collection
40
olaparib
39
Standard of Care
36
Biopsy
33
sacituzumab govitecan
31
130-nm albumin-bound paclitaxel
31
Doxorubicin
30
Exercise
29
eribulin
27
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Geriatric Assessment
×
1 year
×
Clear all
NCT05509751
2026-04-28
SOAR
University of Toronto
Phase NA
Active not recruiting
60 enrolled
NCT07531836
2026-04-15
PREHAB-BC65
Fundacion Miguel Servet
Phase NA
Recruiting
90 enrolled
NCT06125145
2025-12-05
GAP
University of California, Davis
Phase NA
Completed
30 enrolled